The National Institute for Health and Care Excellence (NICE) has released new guidance on type 2 diabetes.
The guideline, Type 2 diabetes in adults: management, has had key areas summarised for primary care professionals and will be distributed with the next issues of Nursing in Practice, Pulse and The Commissioning Review.
The summary, produced with approval from NICE, focuses on tailoring advice and treatments to the person’s circumstances, including considering co-existing illnesses, and reassessing their needs at each review.
Type 2 diabetes occurs when the body doesn't produce enough insulin to function properly, or the body’s cells don't react to insulin. This means that glucose stays in the blood and isn't used as fuel for energy.
According to NHS Choices there are currently 3.9 million people living with diabetes in the UK, with 90% of those affected having type 2 diabetes.
Dr Amanda Adler, consultant diabetologist and NICE guideline developer said: “[The] update to the guideline… is good news for people with type 2 diabetes and for health professionals, given the many therapies now available. The guideline comprehensively covers the best care for patients with type 2 diabetes taking into account effectiveness of medications, enhancing quality of life, and wisely using NHS resources.
“The guideline encourages all patients to eat well and be physically active. For the many adults with type 2 diabetes who do require drugs to help manage their diabetes, the guideline details treatments and includes an algorithm which summarises the range of treatment options at a glance.”
The guideline updates and replaces NICE guideline CG87, NICE guideline CG66, NICE technology appraisal guidance 248 and NICE technology appraisal guidance 203.